Learning Objectives:

  • Review the role of cancer cell-intrinsic oncogene pathways in tumor immune evasion and immunotherapy resistance
  • Discuss work investigating the role of cancer cell-intrinsic HIF-1α or HIF-2α activation in tumor immune evasion and resistance to immune checkpoint blockade 
  • Discuss work investigating the potential role of HIFs as novel therapeutic targets to improve immunotherapy responsiveness
Session date: 
04/17/2023 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jonathan Trujillo, MD, PhD